Rohto Pharmaceutical Co.,Ltd. (TSE:4527), Mitsui & Co., Ltd. (TSE:8031) and others agreed to acquire an 86% stake in Eu Yan Sang International Ltd from Blanca Investments Pte. Ltd., Tower Capital Asia and founding family for approximately SGD 690 million on April 4, 2024. Eu Yan Sang International has net assets of SGD 149.9 million, total assets of SGD 268.1 million, sales of SGD 297.3 million, net income of SGD 18.7 million and core EBITDA of SGD 42.2 million as of June 30, 2023.

Upon the fulfillment of the condition to the Share Acquisition, we will conduct a mandatory general offer for the remaining 14% of the issued ordinary shares of EYS The transaction is expected to complete by June 30, 2024.